By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kiadis Pharma 

Zernikepark 6-8

Groningen    9747 AN  The Netherlands
Phone: 31-0-50-547-42-70 Fax: 31-0-50-547-42-71



Company News
Kiadis Pharma Utilizes BioLife Solutions, Inc. (BLFS.OB) HypoThermosol To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101 T Cell Therapy For Blood Cancers 10/19/2015 9:29:33 AM
European Medicines Agency Grants Kiadis Pharma's Lead Product ATIR ATMP Certificate For Quality And Non-Clinical Data 5/13/2015 6:26:46 AM
Kiadis Pharma Appoints Dr. Vincent Brichard To Its Supervisory Board 5/7/2015 11:45:25 AM
Kiadis Pharma Presents Positive Data From A Pre Specified Interim Analysis Of The Phase 2 Clinical Program With Its Lead Product ATIR 12/9/2014 9:24:07 AM
Kiadis Pharma's Lead Product ATIRâ„¢ Granted Orphan Drug Designation By European Medicines Agency For The Treatment Of Acute Myeloid Leukemia 10/30/2014 10:54:32 AM
Kiadis Pharma Appoints Jeroen Rovers As Its Chief Medical Officer 9/3/2014 11:29:45 AM
Kiadis Pharma Initiates Collaboration For Personalized Immunotherapies Using ATIRTM With Technische Universitat Munchen Within Munich Biotech Cluster 1/29/2014 9:20:00 AM
Kiadis Pharma Participates In Haploidentical Transplantation 2013 Forum 12/5/2013 6:22:55 AM
Kiadis Pharma Provides Positive Update On Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ 11/18/2013 9:21:54 AM
Kiadis Pharma Secures Manufacturing Services Agreement for Its Phase II Clinical Program With Blood Cancer Treatment ATIR™ With the German Red Cross Blood Donor Service 10/7/2013 10:08:49 AM